Prevention & care
Venous blood clots: DVT, pulmonary embolism, tests, and treatment roles
On this page
Venous thromboembolism covers two related problems. Deep vein thrombosis is a clot in a deep vein, often in a leg but sometimes elsewhere. Pulmonary embolism occurs when a clot travels to and blocks a lung blood vessel. The consequences differ from the normal clotting that stops bleeding after injury.[1]
Related clot terms describe different things
| Term | Meaning |
|---|---|
| DVT | A clot in a deep vein; legs and arms are possible sites.[1] |
| Pulmonary embolism | A clot blocking a vessel carrying blood through the lungs.[1] |
| Provoked or unprovoked | Whether a relevant preceding risk factor is identified; the distinction helps later clinical decisions.[5] |
| D-dimer | A fragment produced during clot breakdown; a raised result is not specific proof of DVT or PE.[4] |
Risk has several sources
Major injury, surgery and immobility can contribute to venous clots. Some events have no obvious trigger. The history of a clot and the circumstances around it help guide assessment; a travel story alone is not a diagnosis.[1]
NHS lists additional contexts such as prior DVT, cancer, estrogen-containing medicines, pregnancy and the period after birth. Hospital teams may assess the need for clot prevention during admission and afterward. Prevention is tailored to risk and clinical circumstances, not supplied by a universal supplement or medicine rule.[6]
Leg symptoms and lung symptoms need different attention
DVT can cause pain, swelling and changes in skin colour, commonly in one leg; an arm can also be affected. Skin-colour changes may be harder to see on darker skin. Suspected DVT needs prompt assessment. Signs may be incomplete, so a photograph or symptom checklist cannot confirm or exclude it.[6]
Sudden breathing difficulty, chest or upper-back pain, coughing blood, a very fast heartbeat or collapse can indicate PE or another serious condition. Severe breathing difficulty or collapse needs the local emergency service. New symptoms should not wait for a routine appointment or a home clot test.[7]
Why a positive D-dimer is not a confirmed clot
D-dimer reflects clot formation and breakdown. Pregnancy, recent surgery and other conditions can raise it without the suspected DVT or PE. Results are interpreted with symptoms and clinical likelihood; follow-up imaging may be needed. A low result also has context and limitations, including effects of anticoagulant treatment.[4]
NICE describes clinical probability assessments and pathways that combine D-dimer with imaging. It allows age-adjusted thresholds in selected adults. The order and interpretation of tests depend on the situation, so a number from a laboratory portal should not be used as a stand-alone home rule.[5]
Different scans examine different parts of the problem
Ultrasound can examine blood flow in the affected vein when DVT is suspected. Its place in the pathway depends on clinical assessment and other test results. The urgent-care process should explain whether more assessment is required if symptoms persist or the first test does not settle the question.[6]
For suspected PE, CT pulmonary angiography examines lung blood vessels. A ventilation–perfusion scan compares airflow with blood flow. These are different investigations; suitability can depend on factors such as kidney function and contrast issues. An oxygen reading alone is not a scan for a clot.[2]
Anticoagulants, clot-dissolving drugs, and filters have different roles
Anticoagulants limit clot growth and new clot formation. Thrombolytic medicines actively dissolve clots and are reserved for selected situations because they can cause serious bleeding. A filter or clot-removal procedure has a narrower clinical role; these are not interchangeable substitutes for routine care.[3]
Treatment choice and duration consider the clot, contributing factors, kidney function, cancer or pregnancy context and bleeding risk. NICE separates initial management from decisions about longer-term treatment. One person’s medicine or duration cannot be copied from a general article.[5]
Recovery includes a plan for new symptoms and prevention
Follow-up covers treatment effects, further testing, activity and changing risk. NHS describes hospital prevention and recovery advice. Decisions about travel, pregnancy and procedures need the person’s care plan.[6]
Ongoing symptoms after a lung clot deserve a recovery assessment
After pulmonary embolism, some people continue to have breathlessness or reduced activity. Possible contributors include reduced conditioning, meaning lost physical fitness, other heart or lung illness, psychological effects and chronic clot-related disease. Symptoms should not automatically be labeled another clot, anxiety or permanent damage. Describe what has become difficult and how it is changing.[8]
Follow-up considers function as well as anticoagulation
A European Society of Cardiology working-group position paper, endorsed by the European Respiratory Society, supports assessing function and quality of life, then appropriate clinician-directed investigation and selected rehabilitation. It is professional guidance, not a trial proving one recovery programme. Detailed clot-related pulmonary-hypertension care has its own specialist pathway. These follow-up questions create no generic waiting period: new or worsening symptoms need appropriate assessment using the urgent boundaries above.[8]
Evidence & uncertainty
Symptoms and one blood test do not establish the diagnosis or select treatment. Clinicians combine the likelihood of a clot, test results and imaging. Care must also weigh bleeding risk and the reason a clot occurred. A known risk factor does not prove a clot, and an absent obvious trigger does not rule one out.[5]
Selected-source overview · Independent review pendingPublished questions
How are DVT and pulmonary embolism related?
Selected-source overview · Independent review pending. Read the evidence context.
A deep-vein clot can travel to a lung blood vessel and cause pulmonary embolism.[1]
Evidence behind this answer
- What Is Venous Thromboembolism?
agency condition explanation · 2022
Selected relevant official page passages inspected · DVT/PE relationship, sites and contributing risks
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can deep vein thrombosis affect an arm?
Selected-source overview · Independent review pending. Read the evidence context.
A deep-vein clot can occur in an arm as well as a leg.[1]
Evidence behind this answer
- What Is Venous Thromboembolism?
agency condition explanation · 2022
Selected relevant official page passages inspected · DVT/PE relationship, sites and contributing risks
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a clot always have an obvious preceding trigger?
Selected-source overview · Independent review pending. Read the evidence context.
DVT can occur without an obvious reason; the history still needs assessment.[6]
Evidence behind this answer
- DVT (deep vein thrombosis)
agency patient explanation · 2026
Selected relevant official page passages inspected · Symptoms across skin tones, risks, ultrasound, hospital prevention and follow-up
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does a raised D-dimer confirm pulmonary embolism?
Selected-source overview · Independent review pending. Read the evidence context.
Several conditions can raise it; diagnosis combines clinical assessment and other tests.[4]
Evidence behind this answer
- D-Dimer Test
agency test explanation · Date not stated
Selected relevant official page passages inspected · Clot-breakdown marker, nonspecific elevation, context and follow-up
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Are ultrasound and CT pulmonary angiography the same investigation?
Selected-source overview · Independent review pending. Read the evidence context.
They examine different vessels and questions in DVT and PE pathways.[2]
Evidence behind this answer
- Venous Thromboembolism: Diagnosis
agency patient explanation · 2022
Selected relevant official page passages inspected · Clinical assessment, CT pulmonary angiography and ventilation–perfusion imaging
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Are anticoagulants the same as clot-dissolving medicines?
Selected-source overview · Independent review pending. Read the evidence context.
Limiting clot growth/new formation and actively dissolving clots are different treatment roles.[3]
Evidence behind this answer
- Venous Thromboembolism: Treatment
agency patient explanation · 2022
Selected relevant official page passages inspected · Anticoagulant, thrombolysis and selected procedure/filter roles
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does every venous clot need exactly the same treatment duration?
Selected-source overview · Independent review pending. Read the evidence context.
Duration depends on the clot, its context and the balance of recurrence and bleeding risks.[5]
Evidence behind this answer
- Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158)
clinical guideline · 2023
Selected original guideline indexed passages inspected · Clinical probability, D-dimer/imaging pathways and longer-term decisions
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Do ongoing breathing problems after a lung clot prove another clot has formed?
Selected-source overview · Independent review pending. Read the evidence context.
No. Several problems can affect recovery, including lost fitness and other heart or lung conditions. Appropriate assessment is needed rather than assuming a cause or ignoring symptoms. New or worsening breathing symptoms need urgent medical assessment.[8]
Evidence behind this answer
- Optimal follow-up after acute pulmonary embolism: ESC working-group position paper
professional position paper · 2022
original position paper selected sections read via fallback. Original introduction, post-PE syndrome section, functional assessment/rehabilitation, conclusion and selected safety context; no full evidence appraisal. No independent full evidence appraisal or qualified review completed. · Original introduction, post-PE syndrome section, functional assessment/rehabilitation, conclusion and selected safety context; no full evidence appraisal.
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
References
- What Is Venous Thromboembolism?
Agency condition explanation
NHLBI · Content/publication date: 2022
Accessed: 2026-10-08 UTC · Selected relevant official page passages inspected
Cited sections: DVT/PE relationship, sites and contributing risksUpdated 19 September 2022. Venous disease is distinguished from normal injury-related clotting; no individual risk estimate.
- Venous Thromboembolism: Diagnosis
Agency patient explanation
NHLBI · Content/publication date: 2022
Accessed: 2026-10-08 UTC · Selected relevant official page passages inspected
Cited sections: Clinical assessment, CT pulmonary angiography and ventilation–perfusion imagingUpdated 19 September 2022. No home rule-out based on oxygen or a single blood marker.
- Venous Thromboembolism: Treatment
Agency patient explanation
NHLBI · Content/publication date: 2022
Accessed: 2026-10-08 UTC · Selected relevant official page passages inspected
Cited sections: Anticoagulant, thrombolysis and selected procedure/filter rolesUpdated 20 September 2022. Selected observation pathways are not generalized into advice to leave suspected PE untreated. No doses or universal anesthesia/procedure sequence.
- D-Dimer Test
Agency test explanation
MedlinePlus; US National Library of Medicine · Content/publication date: not stated
Accessed: 2026-10-08 UTC · Selected relevant official page passages inspected
Cited sections: Clot-breakdown marker, nonspecific elevation, context and follow-upSelected result-interpretation passages read. Probability statements are not converted to an unconditional rule-out, particularly during anticoagulation.
- Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158)
Clinical guideline
NICE · Content/publication date: 2023
Accessed: 2026-10-08 UTC · Selected original guideline indexed passages inspected
Cited sections: Clinical probability, D-dimer/imaging pathways and longer-term decisionsPublished 26 March 2020, updated 2 August 2023. Clinical pathways include specified populations and exceptions; no self-scoring or prescribing algorithm supplied.
- DVT (deep vein thrombosis)
Agency patient explanation
NHS · Content/publication date: 2026
Accessed: 2026-10-08 UTC · Selected relevant official page passages inspected
Cited sections: Symptoms across skin tones, risks, ultrasound, hospital prevention and follow-upReviewed 30 April 2026. Pregnancy, surgery and travel decisions require their own context; no universal flight or activity clearance.
- Pulmonary embolism
Agency patient explanation
NHS · Content/publication date: 2023
Accessed: 2026-10-08 UTC · Selected relevant official page passages inspected
Cited sections: Urgent presentation and anticoagulant rolesReviewed 25 May 2023; displayed review-due date has passed. Simplified treatment sequencing and guaranteed-full-recovery wording are not adopted; NICE supplies the clinical framework.
- Optimal follow-up after acute pulmonary embolism: ESC working-group position paper
Professional position paper
Klok FA and ESC working-group colleagues; ERS endorsement · Content/publication date: 2022
Accessed: 2026-10-20 UTC · original position paper selected sections read via fallback. Original introduction, post-PE syndrome section, functional assessment/rehabilitation, conclusion and selected safety context; no full evidence appraisal. No independent full evidence appraisal or qualified review completed.
Cited sections: Original introduction, post-PE syndrome section, functional assessment/rehabilitation, conclusion and selected safety context; no full evidence appraisal.Recovery guidance, not a diagnosis or universal waiting period.
Scope & review
- Population
- Mainly adult venous-clot literacy; pregnancy, cancer and pediatric care need specific pathways
- Exposure or intervention
- DVT/PE, clinical probability, markers, imaging and treatment roles
- Comparison
- Normal clotting versus venous disease; nonspecific marker versus confirmed clot
- Outcomes
- Diagnosis, acute complications, recurrence prevention, bleeding and recovery
- Timeframe
- Urgent suspected events, initial treatment and longer-term reassessment
- Jurisdiction
- US agency explanations and UK NICE 2023/NHS sources with different review dates
Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-08 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.
- 2026-10-20 UTC: Added bounded depth26 explanation after complete target and relevant neighboring-body audit; old section, FAQ and source objects retained exactly. Original-source access and cumulative current/pending work accounting recorded; qualified review remains pending.
What this article still leaves open
- Absolute recurrence/bleeding estimates and comparative treatment evidence by risk group.
- Dedicated accounts of thrombophilia, superficial vein thrombosis, post-thrombotic syndrome and chronic thromboembolic pulmonary hypertension.
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.